Mikko Turunen

2.7k total citations
17 papers, 1.2k citations indexed

About

Mikko Turunen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Mikko Turunen has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Mikko Turunen's work include Epigenetics and DNA Methylation (3 papers), CRISPR and Genetic Engineering (3 papers) and Genomics and Chromatin Dynamics (3 papers). Mikko Turunen is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), CRISPR and Genetic Engineering (3 papers) and Genomics and Chromatin Dynamics (3 papers). Mikko Turunen collaborates with scholars based in Finland, Sweden and United States. Mikko Turunen's co-authors include Jussi Taipale, Teemu Kivioja, Martin Enge, Jian Yan, Markku Varjosalo, Kimmo Palin, Anna Vähärautio, Carsten Carlberg, Martin Bonke and Mikko Taipale and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Mikko Turunen

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikko Turunen Finland 13 810 256 180 159 143 17 1.2k
Kai Doberstein Germany 19 524 0.6× 299 1.2× 249 1.4× 103 0.6× 62 0.4× 27 1.1k
Nils Weinhold United States 12 810 1.0× 282 1.1× 384 2.1× 194 1.2× 192 1.3× 19 1.2k
Sekhar Duraisamy United States 13 653 0.8× 174 0.7× 215 1.2× 94 0.6× 56 0.4× 15 922
Ahmed Raafat United States 19 518 0.6× 569 2.2× 217 1.2× 430 2.7× 110 0.8× 40 1.1k
Lisa Gangi United States 12 671 0.8× 250 1.0× 242 1.3× 110 0.7× 83 0.6× 15 1.1k
Oscar Gee‐Wan Wong Hong Kong 17 603 0.7× 281 1.1× 171 0.9× 56 0.4× 58 0.4× 36 922
Mona L. Gauthier United States 18 591 0.7× 426 1.7× 321 1.8× 166 1.0× 86 0.6× 18 1.1k
Zhiming Zhang China 17 580 0.7× 158 0.6× 238 1.3× 109 0.7× 33 0.2× 53 889
Wei-Lei Yang United States 11 1.1k 1.4× 403 1.6× 360 2.0× 64 0.4× 119 0.8× 11 1.5k
F. Alameda Spain 13 312 0.4× 268 1.0× 117 0.7× 93 0.6× 66 0.5× 28 711

Countries citing papers authored by Mikko Turunen

Since Specialization
Citations

This map shows the geographic impact of Mikko Turunen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko Turunen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko Turunen more than expected).

Fields of papers citing papers by Mikko Turunen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikko Turunen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko Turunen. The network helps show where Mikko Turunen may publish in the future.

Co-authorship network of co-authors of Mikko Turunen

This figure shows the co-authorship network connecting the top 25 collaborators of Mikko Turunen. A scholar is included among the top collaborators of Mikko Turunen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikko Turunen. Mikko Turunen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Worley, Jeremy, Daoqi You, Mikko Turunen, et al.. (2024). Abstract PR01: Identification and pharmacological targeting of treatment-resistant, stem-like breast cancer cells for combination therapy. Cancer Research. 84(3_Supplement_1). PR01–PR01. 1 indexed citations
2.
Rosenberger, George, Mikko Turunen, Jing He, et al.. (2024). Network-based elucidation of colon cancer drug resistance mechanisms by phosphoproteomic time-series analysis. Nature Communications. 15(1). 3909–3909. 6 indexed citations
3.
Korpela, H, et al.. (2021). Gene therapy for ischaemic heart disease and heart failure. Journal of Internal Medicine. 290(3). 567–582. 37 indexed citations
4.
Schmierer, Bernhard, Sandeep K. Botla, Jilin Zhang, et al.. (2017). CRISPR/Cas9 screening using unique molecular identifiers. Molecular Systems Biology. 13(10). 945–945. 43 indexed citations
5.
Heikkinen, Tuomas, Kati Kämpjärvi, Salla Keskitalo, et al.. (2017). Somatic MED12 Nonsense Mutation Escapes mRNA Decay and Reveals a Motif Required for Nuclear Entry. Human Mutation. 38(3). 269–274. 12 indexed citations
6.
Turunen, Mikko, Oliver Mortusewicz, Teemu Kivioja, et al.. (2016). Genome-wide screen of cell-cycle regulators in normal and tumor cells identifies a differential response to nucleosome depletion. Cell Cycle. 16(2). 189–199. 19 indexed citations
7.
Balistreri, Giuseppe, Mikko Turunen, Raquel Díaz, et al.. (2016). Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic Replication. PLoS Pathogens. 12(2). e1005424–e1005424. 28 indexed citations
8.
Haikala, Heidi M., et al.. (2016). Myc requires RhoA/SRF to reprogram glutamine metabolism. Small GTPases. 9(3). 274–282. 18 indexed citations
9.
Turunen, Mikko, Jason M. Spaeth, Salla Keskitalo, et al.. (2014). Uterine Leiomyoma-Linked MED12 Mutations Disrupt Mediator-Associated CDK Activity. Cell Reports. 7(3). 654–660. 123 indexed citations
10.
Bonke, Martin, Mikko Turunen, Anna Vähärautio, et al.. (2013). Transcriptional Networks Controlling the Cell Cycle. G3 Genes Genomes Genetics. 3(1). 75–90. 20 indexed citations
11.
Sur, Inderpreet, Outi Hallikas, Anna Vähärautio, et al.. (2012). Mice Lacking a Myc Enhancer That Includes Human SNP rs6983267 Are Resistant to Intestinal Tumors. Science. 338(6112). 1360–1363. 149 indexed citations
12.
Nikulenkov, Fedor, Clemens Spinnler, Claudia Tonelli, et al.. (2012). Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis. Cell Death and Differentiation. 19(12). 1992–2002. 157 indexed citations
13.
Wei, Gong‐Hong, Gwenaël Badis, Michael F. Berger, et al.. (2010). Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. The EMBO Journal. 29(13). 2147–2160. 433 indexed citations
14.
Malinen, Marjo, et al.. (2010). The Number of Vitamin D Receptor Binding Sites Defines the Different Vitamin D Responsiveness of the CYP24 Gene in Malignant and Normal Mammary Cells. Journal of Biological Chemistry. 285(31). 24174–24183. 36 indexed citations
15.
Turunen, Mikko, Thomas W. Dunlop, Carsten Carlberg, & Sari Väisänen. (2007). Selective use of multiple vitamin D response elements underlies the 1  ,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Research. 35(8). 2734–2747. 76 indexed citations
16.
Turunen, Mikko, Sami Loimas, Pauli Vainio, et al.. (1997). Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model. Clinical Neurology and Neurosurgery. 99. S5–S5. 3 indexed citations
17.
Turunen, Mikko, E Nikkilä, A Voutilainen, & H Teir. (1960). A Retrospective Study of Clinically Undiagnosed Malignant Tumors. Acta Medica Scandinavica. 166(6). 425–432.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026